EGAPP Working Group Meeting, September 25-26, 2006
Hilton Garden Inn Atlanta Airport / Millenium Center – Atlanta, GA
AGENDA
View Meeting Summary
Monday, September 25
|
Time
|
Activity
|
Speaker
|
9:30 – 9:45
|
Welcome – Opening Remarks |
Janet Collins / Muin Khoury
|
9:45 – 10:00
|
Closed Working Group Session called to order |
Al Berg, Chair
|
10:00 – 1:45
|
Presentations of Draft Evidence Reports
- Testing for Hereditary Non-Polyposis Colorectal Cancer (HNPCC) in Newly Diagnosed Colorectal Cancer Patients and Their Family Members
- UGT1A1 Testing in Colorectal Cancer Patients Treated with Irinotecan
|
Evidence-based Practice Center representative, staff and consultants |
|
Commentary and Working Group Responses to Draft Reports |
WG Members |
1:45
|
Adjourn Closed Session
|
Al Berg, Chair |
The Working Group will be meeting in Open Session from 1:45pm to 5:30pm on Monday, September 25
|
1:45 – 2:00
|
Open Session called to order
|
Al Berg, Chair |
2:00 – 2:45
|
Staff Updates on EGAPP Activities
|
Linda Bradley
|
2:45 – 3:00
|
Break |
|
3:00 – 3:30
|
Topics Subcommittee Report
Draft Protocol Manual – draft section discussion on Topic Selection
|
Joan Scott |
3:30 – 4:15
|
Products Subcommittee Report
Discussion of draft documents
Website development and web products
Publication
|
Celia Kaye
|
4:15 – 5:00
|
Methods Subcommittee Report
Recommendation Framework Follow-up
Development of Protocol Manual
|
Steve Teutsch
|
5:00 – 5:15
|
Public Comment Period
|
|
5:15 – 5:30
|
Wrap-up and Adjourn Open Session
|
Al Berg
|
|
The meeting will be in Executive Session (closed to staff and the public) from 8:00 – 9:30 am
on Tuesday, September 26; a Closed Session will follow from 9:30 – 2:00 pm.
Tuesday, September 26
|
Time
|
Activity
|
Speaker
|
9:30 – 2:00
|
Closed Session will address:
Development of Working Group recommendations based on final evidence reviews
- Genetic Tests for Ovarian Cancer Detection and Management
- Testing for Cytochrome P450 Polymorphisms in Adults with Non-Psychotic Depression Treated with Selective Serotonin Reuptake Inhibitors (SSRIs)
Discussion and votes on issues raised
|
Al Berg |
2:00
|
Adjourn |
|
|
Historical Document
Page last updated: June 1, 2009
Page last reviewed: December 23, 2008
Content Source: OPHG Staff